A phospholipids-based in situ-forming gel platform (PG) has been developed.
Concurrent delivery of doxorubicin (DOX) and bromotetrandrin (W198).
The adding of oleic acid provides a new strategy to deliver alkaloids via PG.
Achieved sustained drug release both in vitro and in vivo.
Eliminated toxicity and improved antitumor efficacy by reversing the multidrug resistance.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址:北京市海淀区学院路29号 邮编:100083 电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700 |